Who Just RaisedKelowna, British Columbia, Canada · Health Care · Form D filed Sep 21, 2026
Lexaria Bioscience Corp. raised $113K
Lexaria Bioscience Corp. is a biotechnology company based in Kelowna, British Columbia, Canada. In a Form D filed with the SEC on September 21, 2026, it reported raising $113,492 from 3 investors as part of an offering of up to $113,492. The first sale in the offering took place on September 9, 2026.
Lexaria Bioscience Corp.'s DehydraTECH improves the way APIs enter the bloodstream by promoting more effective oral delivery.
- 15th Form D since 2016. Earlier new notices: Dec 19, 2025 · Oct 1, 2025 · Oct 16, 2024 · May 2, 2024 · Feb 16, 2024 · Oct 4, 2023 and more. All filings on EDGAR
$21.6M raised since 2020
11 Form D offerings, as reported to the SEC, the first in May 13, 2020. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Sep 21, 2026 | $113K | $113K | 3 |
| Dec 19, 2025 | $3.5M | $3.5M | 5 |
| Oct 1, 2025 | $4M | $4M | 5 |
| Oct 16, 2024 | $5M | $5M | 1 |
| May 2, 2024 | $365K | $365K | 1 |
| Feb 16, 2024 | $3.6M | $3.6M | 2 |
| Oct 4, 2023 | $1.6M | $1.6M | 1 |
| Dec 20, 2021 | $1.2M | $1.2M | 1 |
and 3 earlier.
Placement agents: H.C. Wainwright & Co., Maxim Group LLC, Bradley Woods & Co. Ltd.
Lead score
11 out of 100
filed recently website found
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- lexariabioscience.com
- Amount raised
- $113,492
- Offering size
- $113,492
- Investors so far
- 3
- First sale
- September 9, 2026
- Securities offered
- Options or warrants
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Kelowna, British Columbia, Canada
- Incorporated
- Nevada
- Entity type
- Corporation
- Revenue range
- $5,000,001 - $25,000,000
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $113,492 | $113,492 | 3 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Sep 21, 2026 · September 2026 funding report
Similar raises
Estuary Biotherapeutics, Inc.
Menlo Park, CA · filed Oct 16First Form DStill raising
North Elam Ambulatory Surgery Center, LLC
Greensboro, NC · filed Oct 16First Form DStill raising
Immorta Bio, Inc.
Miami Beach, FL · filed Oct 162nd Form D since 2026Still raising
Lamina Surgical, Inc.
Oakland, CA · filed Oct 16
Making Open Surgery Safer | Lamina
First Form DStill raising
J3 Bioscience, Inc.
Salt Lake City, UT · filed Oct 1612th Form D since 2012
Ensho Therapeutics, Inc.
Woodcliff Lake, NJ · filed Oct 155th Form D since 2024Still raising
Light Wave Ownership Path, LLC
Raleigh, NC · filed Oct 1512th Form D since 2019
Immuno Cancer Biotherapeutics, Inc.
Canton, SD · filed Oct 15First Form D